199 related articles for article (PubMed ID: 30927734)
1. Dysfunctional microglia:neuron interactions with significant female bias in a developmental gene x environment rodent model of Alzheimer's disease.
vonderEmbse AN; Hu Q; DeWitt JC
Int Immunopharmacol; 2019 Jun; 71():241-250. PubMed ID: 30927734
[TBL] [Abstract][Full Text] [Related]
2. Developmental toxicant exposure in a mouse model of Alzheimer's disease induces differential sex-associated microglial activation and increased susceptibility to amyloid accumulation.
vonderEmbse AN; Hu Q; DeWitt JC
J Dev Orig Health Dis; 2017 Aug; 8(4):493-501. PubMed ID: 28460650
[TBL] [Abstract][Full Text] [Related]
3. Soluble phospho-tau from Alzheimer's disease hippocampus drives microglial degeneration.
Sanchez-Mejias E; Navarro V; Jimenez S; Sanchez-Mico M; Sanchez-Varo R; Nuñez-Diaz C; Trujillo-Estrada L; Davila JC; Vizuete M; Gutierrez A; Vitorica J
Acta Neuropathol; 2016 Dec; 132(6):897-916. PubMed ID: 27743026
[TBL] [Abstract][Full Text] [Related]
4. Safflower Yellow Improves Synaptic Plasticity in APP/PS1 Mice by Regulating Microglia Activation Phenotypes and BDNF/TrkB/ERK Signaling Pathway.
Pang J; Hou J; Zhou Z; Ren M; Mo Y; Yang G; Qu Z; Hu Y
Neuromolecular Med; 2020 Sep; 22(3):341-358. PubMed ID: 32048142
[TBL] [Abstract][Full Text] [Related]
5. Alzheimer's disease pathological lesions activate the spleen tyrosine kinase.
Schweig JE; Yao H; Beaulieu-Abdelahad D; Ait-Ghezala G; Mouzon B; Crawford F; Mullan M; Paris D
Acta Neuropathol Commun; 2017 Sep; 5(1):69. PubMed ID: 28877763
[TBL] [Abstract][Full Text] [Related]
6. Glucocorticoid receptors modulate dendritic spine plasticity and microglia activity in an animal model of Alzheimer's disease.
Pedrazzoli M; Losurdo M; Paolone G; Medelin M; Jaupaj L; Cisterna B; Slanzi A; Malatesta M; Coco S; Buffelli M
Neurobiol Dis; 2019 Dec; 132():104568. PubMed ID: 31394203
[TBL] [Abstract][Full Text] [Related]
7. Effects of CX3CR1 and Fractalkine Chemokines in Amyloid Beta Clearance and p-Tau Accumulation in Alzheimer's Disease (AD) Rodent Models: Is Fractalkine a Systemic Biomarker for AD?
Merino JJ; Muñetón-Gómez V; Alvárez MI; Toledano-Díaz A
Curr Alzheimer Res; 2016; 13(4):403-12. PubMed ID: 26567742
[TBL] [Abstract][Full Text] [Related]
8. Impaired Src signaling and post-synaptic actin polymerization in Alzheimer's disease mice hippocampus--linking NMDA receptors and the reelin pathway.
Mota SI; Ferreira IL; Valero J; Ferreiro E; Carvalho AL; Oliveira CR; Rego AC
Exp Neurol; 2014 Nov; 261():698-709. PubMed ID: 25128699
[TBL] [Abstract][Full Text] [Related]
9. Microglial response to Alzheimer's disease is differentially modulated by voluntary wheel running and enriched environments.
Rodríguez JJ; Noristani HN; Verkhratsky A
Brain Struct Funct; 2015 Mar; 220(2):941-53. PubMed ID: 24374506
[TBL] [Abstract][Full Text] [Related]
10. Microglial response to LPS increases in wild-type mice during aging but diminishes in an Alzheimer's mouse model: Implication of TLR4 signaling in disease progression.
Go M; Kou J; Lim JE; Yang J; Fukuchi KI
Biochem Biophys Res Commun; 2016 Oct; 479(2):331-337. PubMed ID: 27641666
[TBL] [Abstract][Full Text] [Related]
11. All-trans retinoic acid improved impaired proliferation of neural stem cells and suppressed microglial activation in the hippocampus in an Alzheimer's mouse model.
Takamura R; Watamura N; Nikkuni M; Ohshima T
J Neurosci Res; 2017 Mar; 95(3):897-906. PubMed ID: 27448243
[TBL] [Abstract][Full Text] [Related]
12. Early-life stress lastingly alters the neuroinflammatory response to amyloid pathology in an Alzheimer's disease mouse model.
Hoeijmakers L; Ruigrok SR; Amelianchik A; Ivan D; van Dam AM; Lucassen PJ; Korosi A
Brain Behav Immun; 2017 Jul; 63():160-175. PubMed ID: 28027926
[TBL] [Abstract][Full Text] [Related]
13. GFAP and vimentin deficiency alters gene expression in astrocytes and microglia in wild-type mice and changes the transcriptional response of reactive glia in mouse model for Alzheimer's disease.
Kamphuis W; Kooijman L; Orre M; Stassen O; Pekny M; Hol EM
Glia; 2015 Jun; 63(6):1036-56. PubMed ID: 25731615
[TBL] [Abstract][Full Text] [Related]
14. Glycoprotein NMB: a novel Alzheimer's disease associated marker expressed in a subset of activated microglia.
Hüttenrauch M; Ogorek I; Klafki H; Otto M; Stadelmann C; Weggen S; Wiltfang J; Wirths O
Acta Neuropathol Commun; 2018 Oct; 6(1):108. PubMed ID: 30340518
[TBL] [Abstract][Full Text] [Related]
15. Role of Suppressor of Cytokine Signaling 3 (SOCS3) in Altering Activated Microglia Phenotype in APPswe/PS1dE9 Mice.
Iwahara N; Hisahara S; Kawamata J; Matsumura A; Yokokawa K; Saito T; Fujikura M; Manabe T; Suzuki H; Matsushita T; Suzuki S; Shimohama S
J Alzheimers Dis; 2017; 55(3):1235-1247. PubMed ID: 27814300
[TBL] [Abstract][Full Text] [Related]
16. Molecular and functional signatures in a novel Alzheimer's disease mouse model assessed by quantitative proteomics.
Kim DK; Park J; Han D; Yang J; Kim A; Woo J; Kim Y; Mook-Jung I
Mol Neurodegener; 2018 Jan; 13(1):2. PubMed ID: 29338754
[TBL] [Abstract][Full Text] [Related]
17. Kv1.3 inhibition as a potential microglia-targeted therapy for Alzheimer's disease: preclinical proof of concept.
Maezawa I; Nguyen HM; Di Lucente J; Jenkins DP; Singh V; Hilt S; Kim K; Rangaraju S; Levey AI; Wulff H; Jin LW
Brain; 2018 Feb; 141(2):596-612. PubMed ID: 29272333
[TBL] [Abstract][Full Text] [Related]
18. Accelerated tau pathology with synaptic and neuronal loss in a novel triple transgenic mouse model of Alzheimer's disease.
Saul A; Sprenger F; Bayer TA; Wirths O
Neurobiol Aging; 2013 Nov; 34(11):2564-73. PubMed ID: 23747045
[TBL] [Abstract][Full Text] [Related]
19. REST/NRSF-induced changes of ChAT protein expression in the neocortex and hippocampus of the 3xTg-AD mouse model for Alzheimer's disease.
Orta-Salazar E; Aguilar-Vázquez A; Martínez-Coria H; Luquín-De Anda S; Rivera-Cervantes M; Beas-Zarate C; Feria-Velasco A; Díaz-Cintra S
Life Sci; 2014 Oct; 116(2):83-9. PubMed ID: 25261598
[TBL] [Abstract][Full Text] [Related]
20. The human-specific CASP4 gene product contributes to Alzheimer-related synaptic and behavioural deficits.
Kajiwara Y; McKenzie A; Dorr N; Gama Sosa MA; Elder G; Schmeidler J; Dickstein DL; Bozdagi O; Zhang B; Buxbaum JD
Hum Mol Genet; 2016 Oct; 25(19):4315-4327. PubMed ID: 27516385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
